Managing director Dr. Frank Glatz participated in roundtable discussions on the future of regenerative agriculture Weed ...

This launch is a result of GI acquiring Charles River Laboratories International’s contract and development and managing ...

GI Partners, a leading private investment firm, today announced it has completed the acquisition of the Contract Development ...

Emergent Biosolutions (NYSE:EBS) on Tuesday held its 2026 Annual Meeting of Stockholders, where shareholders voted on ...

Emergent BioSolutions Inc.’s ruination of 15 million doses of COVID-19 vaccine at its Baltimore plant was not as unexpected as the Gaithersburg-based company would have the public believe, an investor ...

Emergent BioSolutions, Inc. (NYSE:EBS) shares surged higher Thursday after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.

(NYSE: EBS) today reported financial results for the first quarter ended March 31, 2026. “Emergent’s first quarter results demonstrate a strong and positive start to 2026, with healthy topline revenue ...

Emergent BioSolutions will be replaced on the S&P SmallCap 600 index. The move is a result of the company's market cap plunging since 2020. S&P Dow Jones Indices said that the change will be effective ...

The stock price of Emergent Biosolutions (NYSE: EBS), a biopharmaceutical company focused on vaccines and antibody therapeutics for infectious diseases, and opioid overdoses, has seen a 17% drop over ...

The European Centre for Disease Prevention and Control raised its risk level for mpox on Friday. The World Health Organization declared a global public health emergency on Wednesday. Emergent ...